Orgenesis secures $5M investment for point-of-care service subsidiary

Published on May 12, 2023

Orgenesis has secured $5 million from Metalmark Capital Partners to accelerate the growth of its point-of-care (POCare) services subsidiary.

Continue reading on website
Other news

AARDEX Group partners with the Digital Medical Society's new project to improve user needs

May 12, 2023
AARDEX Group has joined forces with other industry companies to partner with a new project from The Digital Medical Society (DiMe) called Extending the Verification, Analytical Validation, and Clinical Validation â or V3+ Framework.

REDX inhibitor provides multiple opportunities for cancer associated fibrosis

May 12, 2023
Data from the companyâs lead fibrosis asset called RXC700 has highlighted multiple opportunities for patients with pancreatic ductal adenocarcinoma (PDAC) and triple negative breast cancer (TNBC).